Artificial Intelligence and Robotic Process Automation (RPA) are changing the way we play and work, with novel applications in building and advancing efficient enterprises. Carlos Martin, CEO of macami.ai, will share his insights.

—ATTEND IN PERSON— New drug development is a huge endeavor that can take 15 years, cost > $2B and still have a 80 – 90% failure rate. Now new applications of AI may streamline this process by predictive modeling that increases drug safety, decreases development cost and time to market, and improves overall patient outcomes.